Clinical Trial Update: Efficacy and Safety of Alprostadil Prevent Contrast Induced Nephropathy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assesses the efficacy and safety of alprostadil to prevent contrast-induced nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetes Mellitus
• Kidney Injury

Drugs mentioned

• ALPROSTADIL (ALPROSTADIL)

Snippet

Sponsor: Shanghai 10th People's Hospital | Conditions: Kidney Diseases, Diabetes Mellitus | Phase 4 | Status: UNKNOWN